649-SPYTAC: Peptide Platform for Amyloid-β Degradation

The paper describes the development of SPYTACs, a novel synthetic peptide platform designed to treat Alzheimer’s disease through targeted protein degradation. By utilizing the LRP1 receptor, these bifunctional peptides facilitate the transport of toxic amyloid-β proteins to lysosomes for clearance in both the brain and the liver. Research conducted on 5×FAD mice demonstrates that this technology e...去小宇宙查看完整单集简介
前往小宇宙评论区与主播互动